Evidence map›Paper›PMID 23427109›Full record

ArticleAngewandte Chemie (International ed. in English)2013

Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents.

Song Ding, Xin Qiao, Jimmy Suryadi, Glen S Marrs, Gregory L Kucera, Ulrich Bierbach

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Novel Platinum(II) Tetrazine Complex Capable of Live-Cell IEDDA Reaction.Chembiochem : a European journal of chemical biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Chromatin Regulates Genome Targeting with Cisplatin.Angewandte Chemie (International ed. in English) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Song Ding *Department of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA.
Xin Qiao *Department of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA.
Jimmy SuryadiDepartment of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA.
Glen S MarrsDepartment of Biology, Wake Forest University, Winston-Salem, NC 27109, USA.
Gregory L KuceraDepartment of Internal Medicine, Section on Hematology and Oncology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.
Ulrich BierbachDepartment of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA.

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Novel DNA-metalating Hybrid Anticancer AgentsR01CA101880 · NCI · WAKE FOREST UNIVERSITY · PI BIERBACH, ULRICH · 2003 to 2012
$1.8M
NCI NIH HHS CA101880NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA101880
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Microscopy, ConfocalAcridinesAntineoplastic AgentsCell Line, TumorClick ChemistryDNA, NeoplasmFluorescent DyesHumansHydrazinesPlatinumAcridinesAlexa 488 hydrazideAntineoplastic AgentsDNA, NeoplasmFluorescent DyesHydrazinesPlatinum

Identifiers

PMID23427109
PMCPMC3852910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.